Home
사이트맵
Contact Us
Eng
연구소 소개
연구영역
연구실적
자료실
게시판
×
센터소개
인사말
설립목적
연혁
참여연구진
시설 및 장비
오시는 길
연구영역
임상약물유전체연구부
분자약물유전체연구부
약물유전체연구 지원부
연구실적
중점연구자료
논문실적
학회발표
특허실적
기타실적
자료실
보도자료
사진자료
관련사이트
게시판
행사일정
공지사항
연구소 소식
학계소식
Contact Us
Eng
논문실적
연구실적
중점연구자료
논문실적
학회발표
특허실적
기타실적
지원과제별 :
선택하기
BMRC
BMRC, Japan Fund
BMRC, PRCDM
BMRC, 수송체
cPMTb
FRONTIER
FRONTIER, PRCDM
NRL
NRL, PRCDM
PRCDM
PRCDM, 연구교수
RCTC
RCTC, BMRC
연도별 :
선택하기
2015-International
2015-Domestic
2014-International
2014-Domestic
2013-International
2013-Domestic
2012-International
2012-Domestic
2011-International
2011-Domestic
2010-International
2010-Domestic
2009-International
2009-Domestic
2008-International
2008-Domestic
2007-International
2007-Domestic
2006-International
2006-Domestic
2005-International
2005-Domestic
2004-International
2004-Domestic
2003-International
2003-Domestic
모두보기
·
Anh NK, Phat NK, Yen NTH, Jayanti RP, Thu VTA, Park YJ, Cho YS, Shin JG, Kim DH, Oh JY, Long NP
Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring(cPMTb)
Biomed Pharmacother. 158:114187 / 2023.02 [
LINK
]
·
Jang YN, Cheong WY, Park GR, Kim YM, Ha JB, Ahn SZ
Tumor Microenvironment and Genes Affecting the Prognosis of Temozolomide-Treated Glioblastoma(cPMTb)
J Pers Med. 13(2):188 / 2023.01 [
LINK
]
·
Anh NK, Tung PM, Kim MJ, Long NP, Cho YS, Kim DH, Shin JG
Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS(cPMTb)
Molecules. 27(23):8607 / 2022.12 [
LINK
]
·
Le TK, Park YJ, Cha GS, Oktavia FARH, Kim DH, Yun CH
Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism(cPMTb)
Pharmaceutics. 15(1):23 / 2022.12 [
LINK
]
·
Ahn SZ
Building and analyzing machine learning-based warfarin dose prediction models using scikit-learn(cPMTb)
Transl Clin Pharmacol. 30(4):172-181 / 2022.12 [
LINK
]
·
Sidamo T, Rao PS, Aklillu E, Shibeshi W, Park YM, Cho YS, Shin JG, Heysell SK, Mpagama SG, Engidawork E
Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis(cPMTb)
Infect Drug Resist. 28:15:6839-6852 / 2022.11 [
LINK
]
·
Yen NTH, Park SM, Thu VTA, Phat NK, Cho YS, Yoon SJ, Shin JG, Kim DH, Oh JH, Long NP
Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents(cPMTb)
Life Sci. 1:306:120801 / 2022.10 [
LINK
]
·
Howlader S, Kim MJ, Jony MR, Long NP, Cho YS, Kim DH, Shin JG
Characterization of Clofazimine Metabolism in Human Liver Microsomal Incubation In Vitro(cPMTb)
Antimicrob Agents Chemother. 66(10):e0056522 / 2022.10 [
LINK
]
·
Alhawari H, Jarrar Y, Abulebdah D, Abaalkhail SJ, Alkhalili M, Alkhalili S, Alhawari H, Momani M, Obeidat MN, Fram RK, Salahat MA, Lee SJ
Effects of Vitamin D Receptor Genotype on Lipid Profiles and Retinopathy Risk in Type 2 Diabetes Patients: A Pilot Study(cPMTb)
J Pers Med. 12(9):1488 / 2022.09 [
LINK
]
·
Kim HK, Kim M, Marquez JC, Jeong SH, Ko TH, Noh YH, Kha PT, Choi HM, Kim DH, Kim JT, Yang YI, Ko KS, Rhee BD, Shubina LK, Makarieva TN, Yashunsky DY, Gerbst AG, Nifantiev NE, Stonik VA, Han J
Novel GSK-3β Inhibitor Neopetroside A Protects Against Murine Myocardial Ischemia/Reperfusion Injury(cPMTb)
JACC Basic Transl Sci. 7(11):1102-1116 / 2022.09 [
LINK
]
1
2
3
4
5
6
7
8
9
10
[Next]
제목
저자명
지원과제